Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fit
Abstract
Proteases are key enzymes in viral replication, and interfering with these targets is the basis for therapeutic interventions. We previously introduced a hypothesis about conformational selection in the protease of dengue virus and related flaviviruses, based on conformational plasticity noted in X-ray structures. The present work presents the first functional evidence for alternate recognition by the dengue protease, in a mechanism based primarily on conformational selection rather than induced-fit. Recognition of distinct substrates and inhibitors in proteolytic and binding assays varies to a different extent, depending on factors known to influence the dengue protease structure such as pH and salinity. Furthermore, the buffer type and temperature cause a change in binding, proteolysis, or inhibition behavior. Using representative inhibitors with distinct structural scaffolds, we identify two contrasting binding profiles to dengue protease. Noticeable effects are observed in the binding assay upon inclusion of a non-ionic detergent in comparison to the proteolytic assay. The findings highlight the impact of the selection of testing conditions on the observed ligand affinity or inhibitory potency. From a broader scope, the dengue protease presents an example, where the induced-fit paradigm appears insufficient to explain binding events with the biological target. Furthermore, this protein reveals the complexity of comparing or combining biochemical assay data obtained under different conditions. This can be particularly critical for artificial intelligence (AI) approaches in drug discovery that rely on large datasets compiled from different sources. HIGHLIGHTS- Buffer type, pH, salt, and temperature influence ligand recognition. - Experimental conditions in binding and proteolytic assays affect the obtained data. - Ligand recognition in DENV protease involves mainly conformational selection. Graphic for table of contents O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=84 SRC="FIGDIR/small/589505v1_ufig1.gif" ALT="Figure 1"> View larger version (18K): org.highwire.dtl.DTLVardef@f31595org.highwire.dtl.DTLVardef@10e221borg.highwire.dtl.DTLVardef@e12776org.highwire.dtl.DTLVardef@1e5ecd8_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 3.04
- Field percentile
- top 9%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antiviral Drug Discovery with an Optimized Biochemical Dengue Protease Assay: Improved Predictive Power for Antiviral Efficacy
Johannes Lang, Sudip Kumar Dutta, … Christian D. P. Klein·Antiviral ResearchPeer-reviewed·Dec 5, 2024
- Dengue virus protease activity modulated by dynamics of protease cofactor
- Experimental and In Silico Analysis of the Structural Dynamics of Dengue NS2B-NS3 Protease
Susmida Seni Balakrishnan, SIVARAMAN MANJINI, … Muthuvel Suresh Kumar·bioRxiv·Sep 4, 2026
- Experimental and computational studies on molecular mechanism by which Curcumin allosterically inhibits Dengue protease
J. Song·bioRxiv·Sep 20, 2020
- Infectivity of dengue virus serotypes 1 and 2 is correlated to E protein intrinsic dynamics but not to envelope conformations
K. K. SHARMA, X.-X. LIM, … T. WOHLAND·bioRxiv·Apr 18, 2018
- Identification of novel thiazole derivatives as flaviviral protease inhibitors against DENV and JEV
Sheikh Murtuja, Sayan Das, … Venkatesan Jayaprakash·Antimicrobial Agents and ChemotherapyPeer-reviewed·Feb 24, 2025